The roles and implications of RNA m6A modification in cancer

X Deng, Y Qing, D Horne, H Huang… - Nature Reviews Clinical …, 2023 - nature.com
Abstract N 6-Methyladenosine (m6A), the most prevalent internal modification in eukaryotic
mRNA, has been extensively and increasingly studied over the past decade. Dysregulation …

Role of m6A writers, erasers and readers in cancer

Z Fang, W Mei, C Qu, J Lu, L Shang, F Cao… - … Hematology & Oncology, 2022 - Springer
Abstract The N (6)-methyladenosine (m6A) modification is the most pervasive modification of
human RNAs. In recent years, an increasing number of studies have suggested that m6A …

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism

L Han, L Dong, K Leung, Z Zhao, Y Li, L Gao, Z Chen… - Cell Stem Cell, 2023 - cell.com
Summary N 6-methyladenosine (m 6 A), the most prevalent internal modification in
mammalian mRNAs, is involved in many pathological processes. METTL16 is a recently …

[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

J **, Y **e, JS Zhang, JQ Wang, SJ Dai, W He… - Drug Resistance …, 2023 - Elsevier
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …

Pocketflow is a data-and-knowledge-driven structure-based molecular generative model

Y Jiang, G Zhang, J You, H Zhang, R Yao… - Nature Machine …, 2024 - nature.com
Deep learning-based molecular generation has extensive applications in many fields,
particularly drug discovery. However, the majority of current deep generative models are …

Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins

J Liao, Y Wei, J Liang, J Wen, X Chen, B Zhang… - Cell death …, 2022 - nature.com
Abstract YT521-B homology (YTH) domain-containing proteins (YTHDF1-3, YTHDC1-2) are
the most crucial part of N6-methyladenosine (m6A) readers and play a regulatory role in …

Decoding m6A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance

Y Cheng, Z Gao, T Zhang, Y Wang, X **e, G Han, Y Li… - Cell Stem Cell, 2023 - cell.com
Summary N 6-methyladenosine (m 6 A) is a common chemical modification for mammalian
mRNA and exhibits high dynamics in various biological processes. However, dynamics of m …

[HTML][HTML] RNA N6-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer

B Tan, K Zhou, W Liu, E Prince, Y Qing, Y Li, L Han… - Theranostics, 2022 - ncbi.nlm.nih.gov
Abstract RNA N 6-methyladenosine (m 6 A) modification and its regulators fine tune gene
expression and contribute to tumorigenesis. This study aims to uncover the essential role …

Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases

H Yan, L Zhang, X Cui, S Zheng, R Li - Cell Death Discovery, 2022 - nature.com
Abstract N6-methyladenosine (m6A) is a key area in Epigenetics and has been increasingly
focused these years. In the m6A process, readers recognize the m6A modification on …

The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression

YG Hong, Z Yang, Y Chen, T Liu, Y Zheng, C Zhou… - Cancer research, 2023 - AACR
Abstract N6-methyladenosine (m6A), the most abundant modification in mRNAs, has been
defined as a crucial modulator in the progression of acute myelogenous leukemia (AML) …